Telo Genomics Corp.
TDSGF
$0.07
$0.0057.69%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.87M | -1.73M | -1.91M | -2.00M | -2.20M |
| Total Depreciation and Amortization | 14.70K | 20.00K | 25.50K | 29.20K | 30.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.20K | -35.40K | 10.40K | 41.80K | 100.80K |
| Change in Net Operating Assets | 35.60K | 314.00K | 226.00K | 115.20K | 121.70K |
| Cash from Operations | -1.70M | -1.43M | -1.64M | -1.82M | -1.95M |
| Capital Expenditure | -4.00K | -1.70K | -1.70K | -3.80K | -2.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -1.70K | -1.70K | -3.80K | -2.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -22.50K | -22.50K | -22.50K | -30.00K |
| Issuance of Common Stock | 3.20M | 3.20M | 650.00K | 650.00K | 2.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -258.90K | -258.40K | -38.40K | -40.50K | -209.80K |
| Cash from Financing | 2.11M | 2.09M | 430.30K | 428.70K | 1.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 409.00K | 657.40K | -1.22M | -1.39M | -20.20K |